A Double-Blind, Randomized, Placebo-Controlled Trial of Simvastatin as Add-On Therapy to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Sorensen, Per Soelberg
Lycke, Jan
Eralinna, Juha-Pekka
Edland, Astrid
Wu, Xingchen
Frederiksen, Jette L.
Oturai, Annette Bang
Malmestrom, Clas
Stenager, Egon
Sperling, Bjorn
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：A546 / A547
页数：2
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [2] Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial
    Togha, Mansoureh
    Karvigh, Sanaz Ahmadi
    Nabavi, Masoud
    Moghadam, Nahid Beladi
    Harirchian, Mohammad Hossein
    Sahraian, Mohammad Ali
    Enzevaei, Anahita
    Nourian, Alireza
    Ghanaati, Hossein
    Firouznia, Kavous
    Jannati, Ali
    Shekiba, Majid
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 848 - 854
  • [3] Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
    Sorensen, Per Soelberg
    Lycke, Jan
    Eralinna, Juha-Pekka
    Edland, Astrid
    Wu, Xingchen
    Frederiksen, Jette Lautrup
    Oturai, Annette
    Malmestrom, Clas
    Stenager, Egon
    Sellebjerg, Finn
    Sondergaard, Helle Bach
    LANCET NEUROLOGY, 2011, 10 (08): : 691 - 701
  • [4] No beneficial effect of minocycline as add-on therapy to interferon-β-1a for the treatment of relapsing-remitting multiple sclerosis: results of a large double-blind, randomised, placebo-controlled trial
    Sorensen, P. S.
    Sellebjerg, F.
    Lycke, J.
    Faerkkila, M.
    Creange, A.
    Lund, C.
    Schluep, M.
    Frederiksen, J. L.
    Stenager, E.
    Pfleger, C.
    Garde, E.
    Marhardt, K.
    Garcia Muniz de Carlos, Chuan
    Muniz C., Garcia
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 431 - 432
  • [5] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [6] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [7] NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
    Sorensen, Per Soelberg
    Mellgren, Svein Ivar
    Svenningsson, Anders
    Elovaara, Irina
    Frederiksen, Jette Lautrup
    Beiske, Antonie Giaever
    Myhr, Kjell-Morten
    Sogaard, Lise Vejby
    Olsen, Inge Christoffer
    Wollheim, Magnhild Sandberg
    LANCET NEUROLOGY, 2009, 8 (06): : 519 - 529
  • [8] Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
    Smolders, Joost
    Hupperts, Raymond
    Barkhof, Frederik
    Grimaldi, Luigi M. E.
    Holmoy, Trygve
    Killestein, Joep
    Rieckmann, Peter
    Schluep, Myriam
    Vieth, Reinhold
    Hostalek, Ulrike
    Ghazi-Visser, Lizette
    Beelke, Manolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 (1-2) : 44 - 49
  • [9] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [10] Pharmacokinetics and pharmacodynamics of PEGylated interferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized double-blind placebo-controlled study
    Boyko, A.
    Alifirova, V.
    Boyko, O.
    Greshnova, I.
    Zaslavskiy, L.
    Zakharova, M.
    Parshina, E.
    Poverennova, I.
    Sazonov, D.
    Sokolova, I.
    Shur, S.
    Bakhtiyarova, K.
    Dudin, V.
    Khabirov, F.
    Zinkina-Orikhan, A.
    Linkova, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 911 - 911
12345